Delcath Systems (NASDAQ:DCTH – Get Free Report) is set to issue its quarterly earnings data before the market opens on Tuesday, March 26th. Analysts expect the company to announce earnings of ($0.67) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.
Delcath Systems Price Performance
Shares of Delcath Systems stock opened at $4.68 on Friday. The company has a quick ratio of 3.11, a current ratio of 3.30 and a debt-to-equity ratio of 0.08. The company has a market cap of $103.19 million, a PE ratio of -1.40 and a beta of 0.51. The business has a 50 day moving average of $4.29 and a 200 day moving average of $3.85. Delcath Systems has a 52 week low of $2.25 and a 52 week high of $7.99.
Insider Transactions at Delcath Systems
In related news, Director Gil Aharon bought 26,882 shares of the business’s stock in a transaction dated Tuesday, March 19th. The shares were purchased at an average cost of $3.72 per share, with a total value of $100,001.04. Following the completion of the purchase, the director now owns 1,069,710 shares in the company, valued at approximately $3,979,321.20. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 21.10% of the company’s stock.
Institutional Investors Weigh In On Delcath Systems
About Delcath Systems
Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Featured Stories
- Five stocks we like better than Delcath Systems
- How to Calculate Options Profits
- MarketBeat Week in Review – 3/18 – 3/22
- Pros And Cons Of Monthly Dividend Stocks
- KB Home: Building on Strong Foundations During Volatile Times
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Nike Stock and the 30% Rally That’s Expected
Receive News & Ratings for Delcath Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems and related companies with MarketBeat.com's FREE daily email newsletter.